• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

小肠神经内分泌肿瘤患者的发病率、生存率和预后列线图:一项 SEER 基于人群的研究。

Incidence, survival, and prognostic nomogram of patients with small intestinal neuroendocrine tumors: A SEER population-based study.

机构信息

Department of General Surgery, The First Affiliated Hospital of Soochow University, Suzhou, China.

出版信息

Medicine (Baltimore). 2024 Sep 13;103(37):e39616. doi: 10.1097/MD.0000000000039616.

DOI:10.1097/MD.0000000000039616
PMID:39287239
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11404879/
Abstract

Small intestinal neuroendocrine tumors (SI-NETs) are a group of rare and significantly heterogeneous tumors with limited research currently available. This study aimed to investigate the incidence, survival, and prognostic factors of SI-NETs. We selected data from the surveillance, epidemiology, and end results (SEER) database between 2000 and 2019 and evaluated the incidence trend of SI-NETs during this period. We utilized the Kaplan-Meier method to examine the association between clinical variables and survival rates. Based on the multivariable Cox regression analysis results, we developed a nomogram to predict the 1-, 2-, and 3-year cancer-specific survival (CSS) of SI-NETs patients. We evaluated the consistency, accuracy, and clinical utility of the nomogram by drawing calibration curves, receiver operating characteristic (ROC) curves, and decision curve analysis (DCA) curves. The incidence of SI-NETs showed an upward trend in recent years. Age, grade, T stage, M stage, and primary tumor surgery were independent risk factors for CSS in SI-NETs patients. The nomogram model based on these risk factors showed high accuracy and clinical benefit. SI-NETs are rare tumors with an increasing incidence rate. The nomogram model is expected to be an effective tool for personalized prognosis prediction in SI-NETs patients, which may benefit clinical decision-making.

摘要

小肠神经内分泌肿瘤(SI-NETs)是一组罕见且具有显著异质性的肿瘤,目前相关研究有限。本研究旨在探讨 SI-NETs 的发病率、生存率和预后因素。我们从 2000 年至 2019 年的监测、流行病学和最终结果(SEER)数据库中选择数据,并评估了这期间 SI-NETs 的发病率趋势。我们利用 Kaplan-Meier 方法来检验临床变量与生存率之间的关联。基于多变量 Cox 回归分析结果,我们开发了一个列线图来预测 SI-NETs 患者的 1 年、2 年和 3 年癌症特异性生存率(CSS)。我们通过绘制校准曲线、接收者操作特征(ROC)曲线和决策曲线分析(DCA)曲线来评估该列线图的一致性、准确性和临床实用性。近年来,SI-NETs 的发病率呈上升趋势。年龄、分级、T 分期、M 分期和原发肿瘤手术是 SI-NETs 患者 CSS 的独立危险因素。基于这些危险因素的列线图模型显示出较高的准确性和临床获益。SI-NETs 是一种罕见的肿瘤,发病率呈上升趋势。该列线图模型有望成为 SI-NETs 患者个性化预后预测的有效工具,从而可能有益于临床决策。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1311/11404879/297f66e88d06/medi-103-e39616-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1311/11404879/59d094b606ca/medi-103-e39616-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1311/11404879/d954d92035a7/medi-103-e39616-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1311/11404879/9b77abf30178/medi-103-e39616-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1311/11404879/3844774ce2df/medi-103-e39616-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1311/11404879/eaf313961a9c/medi-103-e39616-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1311/11404879/67126a2e3b5c/medi-103-e39616-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1311/11404879/3b4e9d45d079/medi-103-e39616-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1311/11404879/297f66e88d06/medi-103-e39616-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1311/11404879/59d094b606ca/medi-103-e39616-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1311/11404879/d954d92035a7/medi-103-e39616-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1311/11404879/9b77abf30178/medi-103-e39616-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1311/11404879/3844774ce2df/medi-103-e39616-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1311/11404879/eaf313961a9c/medi-103-e39616-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1311/11404879/67126a2e3b5c/medi-103-e39616-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1311/11404879/3b4e9d45d079/medi-103-e39616-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1311/11404879/297f66e88d06/medi-103-e39616-g008.jpg

相似文献

1
Incidence, survival, and prognostic nomogram of patients with small intestinal neuroendocrine tumors: A SEER population-based study.小肠神经内分泌肿瘤患者的发病率、生存率和预后列线图:一项 SEER 基于人群的研究。
Medicine (Baltimore). 2024 Sep 13;103(37):e39616. doi: 10.1097/MD.0000000000039616.
2
Development and validation of a nomogram for predicting cancer-specific survival in small-bowel adenocarcinoma patients using the SEER database.基于 SEER 数据库的列线图模型构建与验证:用于预测小肠腺癌患者癌症特异性生存的研究。
World J Surg Oncol. 2024 Jun 7;22(1):151. doi: 10.1186/s12957-024-03438-x.
3
A nomogram incorporating treatment data for predicting overall survival in gastroenteropancreatic neuroendocrine tumors: a population-based cohort study.纳入治疗数据的列线图预测胃肠胰神经内分泌肿瘤患者的总生存:一项基于人群的队列研究。
Int J Surg. 2024 Apr 1;110(4):2178-2186. doi: 10.1097/JS9.0000000000001080.
4
Incidence, survival, and prognostic factors for patients with gastrointestinal mixed neuroendocrine non-neuroendocrine neoplasms: a SEER population-based study.胃肠道混合神经内分泌-非神经内分泌肿瘤患者的发病率、生存率和预后因素:一项 SEER 基于人群的研究。
J Cancer Res Clin Oncol. 2023 Nov;149(17):15657-15669. doi: 10.1007/s00432-023-05356-z. Epub 2023 Sep 1.
5
Development of a nomogram model to predict survival outcomes in patients with primary hepatic neuroendocrine tumors based on SEER database.基于 SEER 数据库的原发性肝神经内分泌肿瘤患者生存结局预测列线图模型的建立。
BMC Cancer. 2021 May 18;21(1):567. doi: 10.1186/s12885-021-08337-y.
6
Development and validation of predictive models for distant metastasis and prognosis of gastroenteropancreatic neuroendocrine neoplasms.胃肠胰神经内分泌肿瘤远处转移及预后预测模型的开发与验证
Sci Rep. 2025 Mar 19;15(1):9510. doi: 10.1038/s41598-025-92974-x.
7
Epidemiologic Trends of and Factors Associated With Overall Survival for Patients With Gastroenteropancreatic Neuroendocrine Tumors in the United States.美国胃肠胰神经内分泌肿瘤患者总体生存的流行病学趋势及相关因素。
JAMA Netw Open. 2021 Sep 1;4(9):e2124750. doi: 10.1001/jamanetworkopen.2021.24750.
8
A nomogram to predict postoperative overall and cancer specific survival in patients with primary parotid squamous cell carcinoma: a population based study.预测原发性腮腺鳞状细胞癌患者术后总体生存率和癌症特异性生存率的列线图:一项基于人群的研究。
Sci Rep. 2025 Feb 25;15(1):6774. doi: 10.1038/s41598-025-90480-8.
9
Development of a Nomogram-Based Online Calculator for Predicting Cancer-Specific Survival in Patients With Digestive Tract Mixed Neuroendocrine-Non-Neuroendocrine Neoplasms (MiNENs): An Analysis of the SEER Database.基于列线图的在线计算器的开发,用于预测消化道混合性神经内分泌-非神经内分泌肿瘤(MiNENs)患者的癌症特异性生存率:监测、流行病学和最终结果(SEER)数据库分析
Cancer Rep (Hoboken). 2025 Feb;8(2):e70156. doi: 10.1002/cnr2.70156.
10
A nomogram to assess small-intestinal neuroendocrine tumor ('carcinoid') survival.用于评估小肠神经内分泌肿瘤(“类癌”)生存情况的列线图。
Neuroendocrinology. 2010;92(3):143-57. doi: 10.1159/000319784. Epub 2010 Aug 23.

引用本文的文献

1
Prognosis of NETs: Has There Been Improvement over the Last 30 Years?神经内分泌肿瘤的预后:在过去30年里有改善吗?
Neuroendocrinology. 2025 May 30:1-13. doi: 10.1159/000546613.

本文引用的文献

1
Association of lymph node metastases, grade and extent of mesenteric lymph node dissection in locoregional small intestinal neuroendocrine tumors with recurrence-free survival.局部区域小肠神经内分泌肿瘤的淋巴结转移、分级和肠系膜淋巴结清扫程度与无复发生存率的关系。
J Neuroendocrinol. 2022 Nov;34(11):e13205. doi: 10.1111/jne.13205. Epub 2022 Nov 17.
2
Patterns of Lymph Node Metastasis and Optimal Surgical Strategy in Small (≤20 mm) Gastroenteropancreatic Neuroendocrine Tumors.胃胰神经内分泌肿瘤(≤20mm)的淋巴结转移模式与最佳手术策略。
Front Endocrinol (Lausanne). 2022 Jul 21;13:871830. doi: 10.3389/fendo.2022.871830. eCollection 2022.
3
Primary Tumor Resection is Associated with Improved Disease-Specific Mortality in Patients with Stage IV Small Intestinal Neuroendocrine Tumors (NETs): A Comparison of Upfront Surgical Resection Versus a Watch and Wait Strategy in Two Specialist NET Centers.
原发肿瘤切除术与 IV 期小肠神经内分泌肿瘤(NETs)患者的疾病特异性死亡率改善相关:在两个专科 NET 中心对直接手术切除与观望等待策略进行比较。
Ann Surg Oncol. 2022 Nov;29(12):7822-7832. doi: 10.1245/s10434-022-12030-0. Epub 2022 Jul 16.
4
Survival According to Therapy Regimen for Small Intestinal Neuroendocrine Tumors.小肠神经内分泌肿瘤按治疗方案的生存率
J Clin Med. 2022 Apr 22;11(9):2358. doi: 10.3390/jcm11092358.
5
Epidemiologic Trends of and Factors Associated With Overall Survival for Patients With Gastroenteropancreatic Neuroendocrine Tumors in the United States.美国胃肠胰神经内分泌肿瘤患者总体生存的流行病学趋势及相关因素。
JAMA Netw Open. 2021 Sep 1;4(9):e2124750. doi: 10.1001/jamanetworkopen.2021.24750.
6
Incidence, survival and stage at diagnosis of small intestinal neuroendocrine tumours in Queensland, Australia, 2001-2015.2001-2015 年澳大利亚昆士兰州小肠神经内分泌肿瘤的发病率、生存率和诊断时的分期。
Asia Pac J Clin Oncol. 2021 Aug;17(4):350-358. doi: 10.1111/ajco.13503. Epub 2021 Feb 10.
7
Evolution of the Mesenteric Mass in Small Intestinal Neuroendocrine Tumours.小肠神经内分泌肿瘤中肠系膜肿物的演变
Cancers (Basel). 2021 Jan 25;13(3):443. doi: 10.3390/cancers13030443.
8
Surgery and Perioperative Management in Small Intestinal Neuroendocrine Tumors.小肠神经内分泌肿瘤的手术及围手术期管理
J Clin Med. 2020 Jul 21;9(7):2319. doi: 10.3390/jcm9072319.
9
A Predictive Nomogram for Small Intestine Neuroendocrine Tumors.小肠神经内分泌肿瘤的预测列线图
Pancreas. 2020 Apr;49(4):524-528. doi: 10.1097/MPA.0000000000001526.
10
Management of Small Bowel Neuroendocrine Tumors.小肠神经内分泌肿瘤的治疗。
Surg Oncol Clin N Am. 2020 Apr;29(2):223-241. doi: 10.1016/j.soc.2019.11.006.